iSOFT Agrees on €3.33 Million Primary Care Deal in Spain

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that it renewed a contract, worth €3.33 million (A$5.9 million), to support and maintain its regional primary care solution with the Castilla la Mancha Healthcare Service (SESCAM) in Spain for a further four years.

The agreement includes services, training and maintenance of Turriano, a robust regional primary care solution developed by iSOFT. Turriano is based on iSOFT's e-SIAP solution, and was developed under a 2003 SESCAM contract.

"Turriano is being referenced in other countries such as Portugal and Latin America," said Guillermo Ramas, iSOFT Managing Director for Southern Europe and Latin America. "It is a privilege for iSOFT to help SESCAM offer a quality healthcare service to its citizens with the objective of having a complete primary care medical record."

Turriano links some 200 care centres and more than 1,100 GP surgeries that make up the primary healthcare network across the SESCAM region. About 14,000 family doctors, nurses and other clinical professionals use the software to manage 113,000 appointments and 150,000 prescriptions daily to improve the quality of healthcare services for the region’s more than 2 million patients.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 17 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...